PEDF expression is reduced in prostate, BC, ovarian, and endometrial tumor tissues compared to their counterparts from sound tissues, while an association between PEDF suppression and the effects of sex hormones in the time of preclinical studies was observed. This evidence concerns the gene SERPINF1 and breast cancer.